The exact mechanism by which genetic alteration in UBE2Z can attribute to the CAD risk is not yet clear; however, rs46522 is in strong LD with the causal SNPs in gastric inhibitory peptide (GIP) gene that encodes GIP protein, a protein that modifies the glucose and lipid metabolism potentially mediating known CAD risk factors. Here, GIP is linked to coronary artery disorder.